.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Federal Trade Commission
Julphar
Medtronic
Accenture
Cerilliant
Boehringer Ingelheim
Mallinckrodt
Cipla
Colorcon

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072193

« Back to Dashboard
NDA 072193 describes TRAZODONE HYDROCHLORIDE, which is a drug marketed by Mylan, Watson Labs, Alvogen, Mylan Pharms Inc, Quantum Pharmics, Accord Hlthcare, Teva Pharms Usa, Pliva, Sun Pharm Inds, Am Therap, Zydus Pharms Usa Inc, Teva, Apotex, Torrent Pharms Ltd, Sandoz, Aurolife Pharma Llc, Usl Pharma, Vintage, and Apotex Inc, and is included in twenty-eight NDAs. It is available from forty-four suppliers. Additional details are available on the TRAZODONE HYDROCHLORIDE profile page.

The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are thirteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

Summary for 072193

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 072193

Suppliers and Packaging for NDA: 072193

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL 072193 ANDA Par Pharmaceutical 0603-6161 0603-6161-21 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-6161-21)
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL 072193 ANDA Par Pharmaceutical 0603-6161 0603-6161-28 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-6161-28)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Feb 2, 1989TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Cipla
Boehringer Ingelheim
AstraZeneca
Fish and Richardson
Covington
Express Scripts
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot